1. Home
  2. LASE vs CVKD Comparison

LASE vs CVKD Comparison

Compare LASE & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASE
  • CVKD
  • Stock Information
  • Founded
  • LASE 2019
  • CVKD 2022
  • Country
  • LASE United States
  • CVKD United States
  • Employees
  • LASE N/A
  • CVKD N/A
  • Industry
  • LASE Industrial Machinery/Components
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • LASE Industrials
  • CVKD Health Care
  • Exchange
  • LASE Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • LASE 27.1M
  • CVKD 29.5M
  • IPO Year
  • LASE 2022
  • CVKD 2023
  • Fundamental
  • Price
  • LASE $3.25
  • CVKD $12.11
  • Analyst Decision
  • LASE
  • CVKD Strong Buy
  • Analyst Count
  • LASE 0
  • CVKD 1
  • Target Price
  • LASE N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • LASE 474.3K
  • CVKD 35.2K
  • Earning Date
  • LASE 07-07-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • LASE N/A
  • CVKD N/A
  • EPS Growth
  • LASE N/A
  • CVKD N/A
  • EPS
  • LASE N/A
  • CVKD N/A
  • Revenue
  • LASE $4,962,487.00
  • CVKD N/A
  • Revenue This Year
  • LASE N/A
  • CVKD N/A
  • Revenue Next Year
  • LASE N/A
  • CVKD N/A
  • P/E Ratio
  • LASE N/A
  • CVKD N/A
  • Revenue Growth
  • LASE 23.87
  • CVKD N/A
  • 52 Week Low
  • LASE $1.58
  • CVKD $5.70
  • 52 Week High
  • LASE $19.80
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • LASE 59.56
  • CVKD 49.98
  • Support Level
  • LASE $2.34
  • CVKD $11.00
  • Resistance Level
  • LASE $4.31
  • CVKD $13.56
  • Average True Range (ATR)
  • LASE 0.37
  • CVKD 1.15
  • MACD
  • LASE 0.12
  • CVKD 0.25
  • Stochastic Oscillator
  • LASE 56.17
  • CVKD 80.97

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: